News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Generic Drugmakers Win High Court Patents Ruling on Brand Name Patents; Judge Sides With Caraco Pharmaceutical Laboratories, Ltd. (CPD) Trying to Sell a Lower-cost Version of Novo Nordisk A/S (NVO)’s Prandin


4/18/2012 7:07:17 AM

The U.S. Supreme Court boosted generic-drug makers in seeking federal approval for treatments, saying they can argue in court that their brand-name rivals overstated the reach of their patents in regulatory filings.

The justices today unanimously sided with Caraco Pharmaceutical Laboratories Inc., a generic-drug company trying to sell a lower-cost version of Novo Nordisk AS (NOV) (NOV)’s Prandin diabetes drug.


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES